Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 235

1.

Outcomes by Minimum Inhibitory Concentrations for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.

Andes DR, Ghannoum MA, Mukherjee PK, Kovanda LL, Lu Q, Jones ME, Santerre Henriksen A, Lademacher C, Hope WW.

Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01634-18. doi: 10.1128/AAC.01634-18. [Epub ahead of print]

2.

Effect of an Emollient on the Mycobiome of Atopic Dermatitis Patients.

Chandra J, Retuerto M, Seité S, Martin R, Kus M, Ghannoum MA, Baron E, Mukherjee PK.

J Drugs Dermatol. 2018 Oct 1;17(10):1039-1048.

PMID:
30365583
3.

A Novel Actin Binding Drug with In Vivo Efficacy.

Ravichandran A, Geng M, Hull KG, Li J, Romo D, Lu SE, Albee A, Nutter C, Gordon DM, Ghannoum MA, Lockless SW, Smith L.

Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01585-18. doi: 10.1128/AAC.01585-18. [Epub ahead of print]

4.

Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against Gram-positive pathogens.

Greenberg M, Kuo D, Jankowsky E, Long L, Hager C, Bandi K, Ma D, Manoharan D, Shoham Y, Harte W, Ghannoum MA, Shoham M.

Sci Rep. 2018 Oct 1;8(1):14578. doi: 10.1038/s41598-018-32829-w.

5.

The Gut Microbiome as a Major Regulator of the Gut-Skin Axis.

Salem I, Ramser A, Isham N, Ghannoum MA.

Front Microbiol. 2018 Jul 10;9:1459. doi: 10.3389/fmicb.2018.01459. eCollection 2018. Review.

6.

Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection.

Mukherjee PK, Chandra J, Retuerto M, Tatsuoka C, Ghannoum MA, McComsey GA.

PLoS One. 2018 Jul 11;13(7):e0200285. doi: 10.1371/journal.pone.0200285. eCollection 2018.

7.

Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model.

Hager CL, Larkin EL, Long LA, Ghannoum MA.

J Antimicrob Chemother. 2018 Aug 1;73(8):2085-2088. doi: 10.1093/jac/dky153.

8.

In Vitro and In Vivo Activity of a Novel Catheter Lock Solution against Bacterial and Fungal Biofilms.

Chandra J, Long L, Isham N, Mukherjee PK, DiSciullo G, Appelt K, Ghannoum MA.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00722-18. doi: 10.1128/AAC.00722-18. Print 2018 Aug.

PMID:
29866870
9.

The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn's Disease-Like Ileitis.

Rodriguez-Palacios A, Harding A, Menghini P, Himmelman C, Retuerto M, Nickerson KP, Lam M, Croniger CM, McLean MH, Durum SK, Pizarro TT, Ghannoum MA, Ilic S, McDonald C, Cominelli F.

Inflamm Bowel Dis. 2018 Apr 23;24(5):1005-1020. doi: 10.1093/ibd/izy060.

PMID:
29554272
10.

In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris.

Hager CL, Larkin EL, Long L, Zohra Abidi F, Shaw KJ, Ghannoum MA.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02319-17. doi: 10.1128/AAC.02319-17. Print 2018 Mar.

11.

Biofilms and beyond: expanding echinocandin utility.

Larkin EL, Dharmaiah S, Ghannoum MA.

J Antimicrob Chemother. 2018 Jan 1;73(suppl_1):i73-i81. doi: 10.1093/jac/dkx451.

PMID:
29304214
12.

Bacteriome and mycobiome associations in oral tongue cancer.

Mukherjee PK, Wang H, Retuerto M, Zhang H, Burkey B, Ghannoum MA, Eng C.

Oncotarget. 2017 Oct 19;8(57):97273-97289. doi: 10.18632/oncotarget.21921. eCollection 2017 Nov 14.

13.

Effect of alcohol-based hand rub on hand microbiome and hand skin health in hospitalized adult stem cell transplant patients: A pilot study.

Mukherjee PK, Chandra J, Retuerto M, Arters KA, Consolo MC, Patterson A, Bajaksouzian S, Arbogast JW, Cartner TJ, Jacobs MR, Ghannoum MA, Salata RA.

J Am Acad Dermatol. 2018 Jun;78(6):1218-1221.e5. doi: 10.1016/j.jaad.2017.11.046. Epub 2017 Dec 1. No abstract available.

PMID:
29203437
14.

Relative Resistance of the Emerging Fungal Pathogen Candida auris and Other Candida Species to Killing by Ultraviolet Light.

Cadnum JL, Shaikh AA, Piedrahita CT, Jencson AL, Larkin EL, Ghannoum MA, Donskey CJ.

Infect Control Hosp Epidemiol. 2018 Jan;39(1):94-96. doi: 10.1017/ice.2017.239. Epub 2017 Nov 21.

PMID:
29157326
15.

CD101, a Novel Echinocandin, Possesses Potent Antibiofilm Activity against Early and Mature Candida albicans Biofilms.

Chandra J, Ghannoum MA.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01750-17. doi: 10.1128/AAC.01750-17. Print 2018 Feb.

16.

The mycobiome in HIV.

Hager CL, Ghannoum MA.

Curr Opin HIV AIDS. 2018 Jan;13(1):69-72. doi: 10.1097/COH.0000000000000432. Review.

PMID:
29028668
17.

The mycobiome: Role in health and disease, and as a potential probiotic target in gastrointestinal disease.

Hager CL, Ghannoum MA.

Dig Liver Dis. 2017 Nov;49(11):1171-1176. doi: 10.1016/j.dld.2017.08.025. Epub 2017 Oct 4. Review.

PMID:
28988727
18.

Cetylpyridinium Chloride (CPC) Exhibits Potent, Rapid Activity Against Influenza Viruses in vitro and in vivo.

Popkin DL, Zilka S, Dimaano M, Fujioka H, Rackley C, Salata R, Griffith A, Mukherjee PK, Ghannoum MA, Esper F.

Pathog Immun. 2017;2(2):252-269. doi: 10.20411/pai.v2i2.200. Epub 2017 Jun 26.

19.

Effectiveness of Disinfectants Against Candida auris and Other Candida Species.

Cadnum JL, Shaikh AA, Piedrahita CT, Sankar T, Jencson AL, Larkin EL, Ghannoum MA, Donskey CJ.

Infect Control Hosp Epidemiol. 2017 Oct;38(10):1240-1243. doi: 10.1017/ice.2017.162. Epub 2017 Aug 10.

PMID:
28793937
20.

Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species.

Piedrahita CT, Cadnum JL, Jencson AL, Shaikh AA, Ghannoum MA, Donskey CJ.

Infect Control Hosp Epidemiol. 2017 Sep;38(9):1107-1109. doi: 10.1017/ice.2017.127. Epub 2017 Jul 11.

PMID:
28693657
21.

The Mycobiome: Impact on Health and Disease States.

El-Jurdi N, Ghannoum MA.

Microbiol Spectr. 2017 Jun;5(3). doi: 10.1128/microbiolspec.FUNK-0045-2016. Review.

PMID:
28597821
22.

Establishment and Use of Epidemiological Cutoff Values for Molds and Yeasts by Use of the Clinical and Laboratory Standards Institute M57 Standard.

Lockhart SR, Ghannoum MA, Alexander BD.

J Clin Microbiol. 2017 May;55(5):1262-1268. doi: 10.1128/JCM.02416-16. Epub 2017 Feb 15. Review.

23.

Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections.

Mukherjee PK, Esper F, Buchheit K, Arters K, Adkins I, Ghannoum MA, Salata RA.

BMC Infect Dis. 2017 Jan 14;17(1):74. doi: 10.1186/s12879-016-2177-8.

24.

Metabolomic analysis identifies differentially produced oral metabolites, including the oncometabolite 2-hydroxyglutarate, in patients with head and neck squamous cell carcinoma.

Mukherjee PK, Funchain P, Retuerto M, Jurevic RJ, Fowler N, Burkey B, Eng C, Ghannoum MA.

BBA Clin. 2016 Dec 18;7:8-15. doi: 10.1016/j.bbacli.2016.12.001. eCollection 2017 Jun.

25.

Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.

Mukherjee PK, Chen H, Patton LL, Evans S, Lee A, Kumwenda J, Hakim J, Masheto G, Sawe F, Pho MT, Freedberg KA, Shiboski CH, Ghannoum MA, Salata RA; Oral HIVAIDS Research Alliance (OHARA)AIDS Clinical Trials Group (ACTG) 5265 Team.

AIDS. 2017 Jan 2;31(1):81-88.

26.

Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.

Hoarau G, Mukherjee PK, Gower-Rousseau C, Hager C, Chandra J, Retuerto MA, Neut C, Vermeire S, Clemente J, Colombel JF, Fujioka H, Poulain D, Sendid B, Ghannoum MA.

MBio. 2016 Sep 20;7(5). pii: e01250-16. doi: 10.1128/mBio.01250-16.

27.

Clinical Effects of Gamma-Radiation-Resistant Aspergillus sydowii on Germ-Free Mice Immunologically Prone to Inflammatory Bowel Disease.

Rodriguez-Palacios A, Aladyshkina N, Retuerto M, Hager CL, Ilic S, Ghannoum MA, Cominelli F.

J Pathog. 2016;2016:5748745. doi: 10.1155/2016/5748745. Epub 2016 Aug 18.

28.

Admission to the Intensive Care Unit is Associated With Changes in the Oral Mycobiome.

Watkins RR, Mukherjee PK, Chandra J, Retuerto MA, Guidry C, Haller N, Paranjape C, Ghannoum MA.

J Intensive Care Med. 2017 May;32(4):278-282. doi: 10.1177/0885066615627757. Epub 2016 Feb 17.

PMID:
26893317
29.
30.

Quorum-sensing dysbiotic shifts in the HIV-infected oral metabiome.

Brown RE, Ghannoum MA, Mukherjee PK, Gillevet PM, Sikaroodi M.

PLoS One. 2015 Apr 17;10(4):e0123880. doi: 10.1371/journal.pone.0123880. eCollection 2015.

31.

VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model.

Garvey EP, Hoekstra WJ, Moore WR, Schotzinger RJ, Long L, Ghannoum MA.

Antimicrob Agents Chemother. 2015 Apr;59(4):1992-7. doi: 10.1128/AAC.04902-14. Epub 2015 Jan 20.

32.

Ability of hydroxypropyl chitosan nail lacquer to protect against dermatophyte nail infection.

Ghannoum MA, Long L, Isham N, Bulgheroni A, Setaro M, Caserini M, Palmieri R, Mailland F.

Antimicrob Agents Chemother. 2015 Apr;59(4):1844-8. doi: 10.1128/AAC.04842-14. Epub 2014 Dec 29.

33.

Multilaboratory testing of antifungal drug combinations against Candida species and Aspergillus fumigatus: utility of 100 percent inhibition as the endpoint.

Ren P, Luo M, Lin S, Ghannoum MA, Isham N, Diekema DJ, Pfaller MA, Messer S, Lockhart SR, Iqbal N, Chaturvedi V.

Antimicrob Agents Chemother. 2015 Mar;59(3):1759-66. doi: 10.1128/AAC.04545-14. Epub 2014 Dec 15.

34.

Mycobiota in gastrointestinal diseases.

Mukherjee PK, Sendid B, Hoarau G, Colombel JF, Poulain D, Ghannoum MA.

Nat Rev Gastroenterol Hepatol. 2015 Feb;12(2):77-87. doi: 10.1038/nrgastro.2014.188. Epub 2014 Nov 11. Review.

PMID:
25385227
35.

In vitro effect of over-the-counter probiotics on the ability of Candida albicans to form biofilm on denture strips.

Ujaoney S, Chandra J, Faddoul F, Chane M, Wang J, Taifour L, Mamtani MR, Thakre TP, Kulkarni H, Mukherjee P, Ghannoum MA.

J Dent Hyg. 2014 Jun;88(3):183-9.

PMID:
24935148
36.

Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253.

Shiboski CH, Chen H, Ghannoum MA, Komarow L, Evans S, Mukherjee PK, Isham N, Katzenstein D, Asmelash A, Omozoarhe AE, Gengiah S, Allen R, Tripathy S, Swindells S; AIDS Clinical Trials Group Network and Oral HIV/AIDS Research Alliance.

Int J Tuberc Lung Dis. 2014 Jun;18(6):682-8. doi: 10.5588/ijtld.13.0729.

37.

Animal models to investigate fungal biofilm formation.

Chandra J, Pearlman E, Ghannoum MA.

Methods Mol Biol. 2014;1147:141-57. doi: 10.1007/978-1-4939-0467-9_10.

PMID:
24664831
38.

Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi.

Mukherjee PK, Chandra J, Retuerto M, Sikaroodi M, Brown RE, Jurevic R, Salata RA, Lederman MM, Gillevet PM, Ghannoum MA.

PLoS Pathog. 2014 Mar 13;10(3):e1003996. doi: 10.1371/journal.ppat.1003996. eCollection 2014 Mar.

39.

Novel role of a family of major facilitator transporters in biofilm development and virulence of Candida albicans.

Shah AH, Singh A, Dhamgaye S, Chauhan N, Vandeputte P, Suneetha KJ, Kaur R, Mukherjee PK, Chandra J, Ghannoum MA, Sanglard D, Goswami SK, Prasad R.

Biochem J. 2014 Jun 1;460(2):223-35. doi: 10.1042/BJ20140010.

PMID:
24621232
40.

Silicon phthalocyanine 4 phototoxicity in Trichophyton rubrum.

Lam M, Dimaano ML, Oyetakin-White P, Retuerto MA, Chandra J, Mukherjee PK, Ghannoum MA, Cooper KD, Baron ED.

Antimicrob Agents Chemother. 2014 Jun;58(6):3029-34. doi: 10.1128/AAC.01448-13. Epub 2014 Mar 10.

41.

The natural diyne-furan fatty acid EV-086 is an inhibitor of fungal delta-9 fatty acid desaturation with efficacy in a model of skin dermatophytosis.

Knechtle P, Diefenbacher M, Greve KB, Brianza F, Folly C, Heider H, Lone MA, Long L, Meyer JP, Roussel P, Ghannoum MA, Schneiter R, Sorensen AS.

Antimicrob Agents Chemother. 2014;58(1):455-66. doi: 10.1128/AAC.01443-13. Epub 2013 Nov 4.

42.

The RodA hydrophobin on Aspergillus fumigatus spores masks dectin-1- and dectin-2-dependent responses and enhances fungal survival in vivo.

Carrion Sde J, Leal SM Jr, Ghannoum MA, Aimanianda V, Latgé JP, Pearlman E.

J Immunol. 2013 Sep 1;191(5):2581-8. doi: 10.4049/jimmunol.1300748. Epub 2013 Aug 7.

43.

Molecular analysis of dermatophytes suggests spread of infection among household members.

Ghannoum MA, Mukherjee PK, Warshaw EM, Evans S, Korman NJ, Tavakkol A.

Cutis. 2013 May;91(5):237-45.

PMID:
23772429
44.

Efficacy of NVC-422 in the treatment of dermatophytosis caused by Trichophyton mentagrophytes using a guinea pig model.

Ghannoum MA, Long L, Cirino AJ, Miller AR, Najafi R, Wang L, Sharma K, Anderson M, Memarzadeh B.

Int J Dermatol. 2013 May;52(5):567-71. doi: 10.1111/j.1365-4632.2012.05477.x.

PMID:
23590371
45.

Optimization of an infected shoe model for the evaluation of an ultraviolet shoe sanitizer device.

Ghannoum MA, Isham N, Long L.

J Am Podiatr Med Assoc. 2012 Jul-Aug;102(4):309-13.

PMID:
22826329
46.

Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.

Pfaller MA, Chaturvedi V, Diekema DJ, Ghannoum MA, Holliday NM, Killian SB, Knapp CC, Messer SA, Miskou A, Ramani R.

Diagn Microbiol Infect Dis. 2012 Aug;73(4):365-8. doi: 10.1016/j.diagmicrobio.2012.05.008. Epub 2012 Jun 20.

PMID:
22726528
47.

Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.

Mukherjee PK, Chandra J, Yu C, Sun Y, Pearlman E, Ghannoum MA.

Invest Ophthalmol Vis Sci. 2012 Jul 3;53(8):4450-7. doi: 10.1167/iovs.12-9848.

48.

Disruption of the ECM33 gene in Candida albicans prevents biofilm formation, engineered human oral mucosa tissue damage and gingival cell necrosis/apoptosis.

Rouabhia M, Semlali A, Chandra J, Mukherjee P, Chmielewski W, Ghannoum MA.

Mediators Inflamm. 2012;2012:398207. doi: 10.1155/2012/398207. Epub 2012 May 14.

49.

Nonspecific effect of Mycograb on amphotericin B MIC.

Richie DL, Ghannoum MA, Isham N, Thompson KV, Ryder NS.

Antimicrob Agents Chemother. 2012 Jul;56(7):3963-4. doi: 10.1128/AAC.00435-12. Epub 2012 Apr 16.

50.

Efficacy of care solutions against contact lens-associated Fusarium biofilms.

Retuerto MA, Szczotka-Flynn L, Ho D, Mukherjee P, Ghannoum MA.

Optom Vis Sci. 2012 Apr;89(4):382-91. doi: 10.1097/OPX.0b013e31824cb754.

PMID:
22426175

Supplemental Content

Loading ...
Support Center